It is well known that antibiotic-resistant microbes are becoming increasingly prevalent and that traditional antibiotics cannot cope with this growing threat. In this worrisome scenario,… Read More »Are endolysins the novel antibiotics?
The toxin-antitoxin systems are a set of two closely linked genes. One encodes the “toxin”, while the other its corresponding “antitoxin” that counteracts the toxic… Read More »A new antitoxin mechanism could neutralize different toxins and protect bacteria from bacteriophages
Results of the most comprehensive analysis to date are pretty worrying. It is widely known that bacteria resistance to antibiotics and other antimicrobial drugs poses… Read More »How many deaths caused antimicrobial resistance in 2019?
Pamplona, Barcelona, 13th July 2020 – Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic… Read More »Telum Therapeutics raises € 4.1 million in its first round of financing to advance the development of new synthetic biology-based therapies for the treatment of infectious diseases caused by multi-resistant bacteria.
